Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ligand Pharmaceuticals (LGND) Shares Outstanding (Diluted Average) (2016 - 2025)

Ligand Pharmaceuticals' Shares Outstanding (Diluted Average) history spans 16 years, with the latest figure at $20.3 million for Q4 2025.

  • For Q4 2025, Shares Outstanding (Diluted Average) rose 10.96% year-over-year to $20.3 million; the TTM value through Dec 2025 reached $20.3 million, up 10.96%, while the annual FY2025 figure was $20.3 million, 10.96% up from the prior year.
  • Shares Outstanding (Diluted Average) for Q4 2025 was $20.3 million at Ligand Pharmaceuticals, down from $20.6 million in the prior quarter.
  • Across five years, Shares Outstanding (Diluted Average) topped out at $20.6 million in Q3 2025 and bottomed at $16.8 million in Q1 2022.
  • The 5-year median for Shares Outstanding (Diluted Average) is $17.7 million (2023), against an average of $18.0 million.
  • The largest annual shift saw Shares Outstanding (Diluted Average) dropped 2.46% in 2022 before it grew 11.06% in 2025.
  • A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $17.2 million in 2021, then dropped by 2.19% to $16.9 million in 2022, then increased by 5.27% to $17.8 million in 2023, then increased by 3.0% to $18.3 million in 2024, then increased by 10.96% to $20.3 million in 2025.
  • Per Business Quant, the three most recent readings for LGND's Shares Outstanding (Diluted Average) are $20.3 million (Q4 2025), $20.6 million (Q3 2025), and $19.9 million (Q2 2025).